OpenFilings

REGENERON PHARMACEUTICALS, INC.

Form10-K

Report Period2023-12-31

Date Filed2024-02-05

Time Filed09:16:15

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
STOCK OPTION AGREEMENT (NQ) - EXECUTIVE OFFICERS
RESTRICTED STOCK AGREEMENT - EXECUTIVE OFFICERS
SUBSIDIARIES OF THE REGISTRANT
CONSENT OF PRICEWATERHOUSECOOPERS LLP
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
CLAWBACK POLICY
Filing on SEC Edgar